Joseph Payne
Vermögen: 20 Mio $ am 30.09.2026
Vermögen: 20 Mio $ am 30.09.2026
Mr. Joseph E.
Payne is a President, Chief Executive Officer & Director at Arcturus Therapeutics Holdings, Inc. and a President, Chief Executive Officer & Director at Arcturus Therapeutics Ltd. He is on the Board of Directors at Arcturus Therapeutics Holdings, Inc. and Arcturus Therapeutics Ltd. Mr. Payne was previously employed as an Independent Director by Vallon Pharmaceuticals, Inc., a President & Chief Executive Officer by Arcturus Therapeutics, Inc., a Senior Manager by Nitto Denko Corp., a Principal by Bristol Myers Squibb Co., a Staff Scientist by DuPont Pharmaceuticals Co., and a Research Scientist by Merck Research Laboratories Massachusetts LLC.
He received his undergraduate degree from Brigham Young University and a graduate degree from the University of Calgary.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.04.2026 | 1.480.097 ( 5,45 % ) | 20 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Vorstandsvorsitzender | 01.03.2013 |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Gründer | 01.03.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
| GRI BIOPAR | Direktor/Vorstandsmitglied | 21.04.2023 |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Vorstandsvorsitzender | 01.02.2018 |
| NITTO DENKO CORPORATION | Corporate Officer/Principal | 01.02.2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
Nitto Denko Corp.
Nitto Denko Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures and sells information functional materials & printed circuits and adhesive tapes | Electronic Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Vallon Pharmaceuticals, Inc.
Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen